These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
6. Simvastatin treatment reduces heat shock protein 60, 65, and 70 antibody titers in dyslipidemic patients: A randomized, double-blind, placebo-controlled, cross-over trial. Moohebati M; Bidmeshgi S; Azarpazhooh MR; Daloee MH; Ghayour-Mobarhan M; Tavallaie S; Amini M; Momenzadeh A; Sahebkar A; Paydar R; Rahsepar AA; Parizadeh SM; Akhlaghi S; Ferns GA Clin Biochem; 2011 Feb; 44(2-3):192-7. PubMed ID: 20875810 [TBL] [Abstract][Full Text] [Related]
7. MRC/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial. Collins R; Armitage J; Parish S; Sleigh P; Peto R; Lancet; 2003 Jun; 361(9374):2005-16. PubMed ID: 12814710 [TBL] [Abstract][Full Text] [Related]
8. Simvastatin treatment prevents oxidative damage to DNA in whole blood leukocytes of dyslipidemic type 2 diabetic patients. Manfredini V; Biancini GB; Vanzin CS; Dal Vesco AM; Cipriani F; Biasi L; Treméa R; Deon M; Peralba Mdo C; Wajner M; Vargas CR Cell Biochem Funct; 2010 Jul; 28(5):360-6. PubMed ID: 20589733 [TBL] [Abstract][Full Text] [Related]
9. Prognostic Factors Associating with Pro-oxidant-antioxidant Balance; Neutrophils to Lymphocytes Ratio, Vitamin D, Heat Shock Protein 27, and Red Cell Distribution Width. Ghazizadeh H; Mirinezhad MR; Seyedi SMR; Sadabadi F; Ahmadnezhad M; Jaberi N; Pasdar A; Ferns GA; Esmaily H; Ghayour-Mobarhan M Arch Med Res; 2020 Apr; 51(3):261-267. PubMed ID: 32111498 [TBL] [Abstract][Full Text] [Related]
10. Prooxidant-antioxidant balance as a new risk factor in patients with angiographically defined coronary artery disease. Alamdari DH; Ghayour-Mobarhan M; Tavallaie S; Parizadeh MR; Moohebati M; Ghafoori F; Kazemi-Bajestani SM; Paletas K; Pegiou T; Koliakos G Clin Biochem; 2008 Apr; 41(6):375-80. PubMed ID: 18191639 [TBL] [Abstract][Full Text] [Related]
11. Effects of cholesterol-lowering with simvastatin on stroke and other major vascular events in 20536 people with cerebrovascular disease or other high-risk conditions. Collins R; Armitage J; Parish S; Sleight P; Peto R; Lancet; 2004 Mar; 363(9411):757-67. PubMed ID: 15016485 [TBL] [Abstract][Full Text] [Related]
12. Curcuminoids modulate pro-oxidant-antioxidant balance but not the immune response to heat shock protein 27 and oxidized LDL in obese individuals. Sahebkar A; Mohammadi A; Atabati A; Rahiman S; Tavallaie S; Iranshahi M; Akhlaghi S; Ferns GA; Ghayour-Mobarhan M Phytother Res; 2013 Dec; 27(12):1883-8. PubMed ID: 23494802 [TBL] [Abstract][Full Text] [Related]
13. Relationship between prooxidant-antioxidant balance and severity of coronary artery disease in patients of Imam Khomeini Hospital of Tehran, Iran. Nabatchican F; Einollahi N; Kazemi Khaledi A Acta Med Iran; 2014; 52(2):116-21. PubMed ID: 24659068 [TBL] [Abstract][Full Text] [Related]
14. Association between C-reactive protein, pro-oxidant-antioxidant balance and traditional cardiovascular risk factors in an Iranian population. Razavi A; Baghshani MR; Rahsepar AA; Mohaddes Ardabili H; Sheikh Andalibi MS; Reza Parizadeh SM; Tavallaie S; Mousavi S; Ghayour-Mobarhan M; Ferns G Ann Clin Biochem; 2013 Mar; 50(Pt 2):115-21. PubMed ID: 23440541 [TBL] [Abstract][Full Text] [Related]
15. Prooxidant-antioxidant balance and antioxidized LDL antibody level values and cardiac function in patients with coronary artery disease. Rahsepar AA; Mirzaee A; Moodi F; Moohebati M; Tavallaie S; Eshraghi A; Alavi MS; Khorashadizadeh F; Pourghadamyari H; Paydar R; Amini M; Khojasteh R; Mousavi S; Sahebi M; Ghayour-Mobarhan M; Ferns GA Cardiology; 2012; 122(4):203-9. PubMed ID: 22854352 [TBL] [Abstract][Full Text] [Related]
16. The effect of aggressive versus conventional lipid-lowering therapy on markers of inflammatory and oxidative stress. Mulder DJ; van Haelst PL; Wobbes MH; Gans RO; Zijlstra F; May JF; Smit AJ; Tervaert JW; van Doormaal JJ Cardiovasc Drugs Ther; 2007 Apr; 21(2):91-7. PubMed ID: 17342417 [TBL] [Abstract][Full Text] [Related]
17. The effect of curcumin with piperine supplementation on pro-oxidant and antioxidant balance in patients with non-alcoholic fatty liver disease: a randomized, double-blind, placebo-controlled trial. Mirhafez SR; Farimani AR; Gholami A; Hooshmand E; Tavallaie S; Nobakht M Gh BF Drug Metab Pers Ther; 2019 May; 34(2):. PubMed ID: 31145689 [TBL] [Abstract][Full Text] [Related]